Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Total Current Liabilities

    Back to Balance Sheet
INDO US BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDO US BIOTECH Last 5 Year Total Current Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹16 Cr₹17 Cr₹12 Cr₹12 Cr₹18 Cr

What is the latest Total Current Liabilities ratio of INDO US BIOTECH ?

The latest Total Current Liabilities ratio of INDO US BIOTECH is ₹16 Cr based on Mar2025 Standalone results.
Year Total Current Liabilities
Mar2025₹16 Cr
Mar2024₹17 Cr
Mar2023₹12 Cr
Mar2022₹12 Cr
Mar2021₹18 Cr

How is Total Current Liabilities of INDO US BIOTECH Trending?

Years Total Current Liabilities % Change
Mar2025 ₹16 Cr
-6.44
Mar2024 ₹17 Cr
42.06
Mar2023 ₹12 Cr
0.70
Mar2022 ₹12 Cr
-32.03
Mar2021 ₹18 Cr -

Compare Total Current Liabilities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹201.0 Cr -0.6% -21.5% -48.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,447.6 Cr -4.1% -17.5% -10.9% Stock Analytics
KAVERI SEED COMPANY ₹4,178.7 Cr 0.7% -10% -23.7% Stock Analytics
VENKYS (INDIA) ₹1,716.8 Cr -6.2% -17.1% -25% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹856.3 Cr -2.9% -8.7% -38.8% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹328.2 Cr -2.5% -21.6% -34.2% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-0.6%

-21.5%

-48.6%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses